BioSpace News Archive

GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that clinicians have treated the first patient in a Phase 1b/2 study evaluating the company’s lead drug candidate, uproleselan, added to cladribine plus low dose cytarabine (LDAC) in patients with treated secondary AML (ts-AML).

Adamas Pharmaceuticals, Inc. today announces the issuance of two patents covering GOCOVRI® (amantadine) extended-release capsules: U.S. Patent No. 11,065,213 issued on July 20, 2021, and U.S. Patent No. 11,077,073, projected to issue on August 3, 2021.

Lixte Biotechnology Holdings, Inc commented on pre-clinical research demonstrating that inhibition of protein phosphatase 2A (PP2A) with LB-100 combined with the experimental drug, vosoritide (BioMarin), was even more effective than vosorotide alone in stimulating bone length and cartilage area.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has added to its suite of intellectual property protection after being awarded a patent from the Republic of Korea’s Intellectual Property Office for the Company’s CoPrimer™ technology.

The emergence and spread of antimicrobial resistance have been identified as a significant problem for human health that profoundly impacts clinical outcomes and healthcare-associated costs.

According to The Insight Partners market research titled ‘Colorectal Cancer to 2027 – Global Analysis and Forecasts by Modality, and End User’.

The Ventilator market was valued at US$ 2,620.45 million in 2019and is projected to reach US$ 8,239.18 million by 2027; it is expected to grow at a CAGR of 12.9% from 2020to 2027.

The home diagnostics for urinary tract infection market was valued at US$ 847.85 million in 2019 and is expected reach US$ 1,354.02 million by 2027; it is projected to grow at a CAGR of 6.2% from 2020 to 2027.

About one in four blood cancer patients fail to produce detectable antibodies after COVID-19 vaccination, but results vary substantially by type of blood cancer, according to a new study from The Leukemia & Lymphoma Society (LLS) that was published today in the journal Cancer Cell.

The Lupus Foundation of America announced six recipients of the 2021 Gina M. Finzi Memorial Student Summer Fellowship Program.